The controlling shareholders of the Promedico company
continued withdrawing millions of dollars from the
company in a manner constituting a prima facie violation
of law, even after an overt investigation was inaugurated
against them in 1993.
Information reaching Globes indicates that at the time
the investigation was launched (in 1993), the tax amount
allegedly concealed from the Income Tax Commission stood
at $14 million. In the course of the investigation it
became apparent that the company's present controlling
shareholders - Binyamin Jesselsohn and Alexander
Eisenberg - continued paying moneys out of Promedico, by
way of commissions, without paying tax thereon.
The volume of the alleged tax concealment involving
all the suspects, including Teva's general manager Eli
Hurvitz, amounts, together with linkage and interest, to
about twenty million dollars.
It was also reported that under questioning, and in
conversation with legal counsel, Jesselsohn and Eisenberg
alleged that they had continued taking funds out in the
same manner, due to their basic concept whereby neither
they nor the company were under any obligation to pay tax
in Israel on moneys paid as commission. This plea was
later rejected by the prosecuting attorney and the income
tax investigators.
Counsel for the suspects refused to comment on the
details of the case, since a hearing is presently in
progress